0

Fasentin

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP392721378
CAS392721-37-8
MDL NumberMFCD01001285
Molecular Weight279.64
InChI KeyGNYIJZMBLZXJEJ-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: >10 mg/mL
Assay≥98% (HPLC)
Colorwhite to off-white
Formpowder
Size5MG, 25MG
Storage Conditionsroom temp
1

A Novel Inhibitor of Glucose Uptake Sensitizes Cells to FAS-induced Cell Death

Tabitha E Wood, Shadi Dalili, Craig D Simpson, Rose Hurren, Xinliang Mao, Fernando Suarez Saiz, Marcela Gronda, Yanina Eberhard, Mark D Minden, Philip J Bilan, Amira Klip, Robert A Batey, Aaron D Schimmer

Mol Cancer Ther. 2008 Nov;7(11):3546-55.

PMID: 19001437

1

Glucocorticoids Reduce Chemotherapeutic Effectiveness on OSCC Cells via Glucose-Dependent Mechanisms

Antonio Celentano, Michael McCullough, Nicola Cirillo

J Cell Physiol. 2019 Mar;234(3):2013-2020.

PMID: 30240006

1

GLUT1 and TUBB4 in Glioblastoma Could Be Efficacious Targets

Maheedhara R Guda, Collin M Labak, Sara Ibrahim Omar, Swapna Asuthkar, Subra Airala, Jack Tuszynski, Andrew J Tsung, Kiran K Velpula

Cancers (Basel). 2019 Sep 5;11(9):1308.

PMID: 31491891

1

Targeting Glucose Metabolism to Suppress Cancer Progression: Prospective of Anti-Glycolytic Cancer Therapy

Ali F Abdel-Wahab, Waheed Mahmoud, Randa M Al-Harizy

Pharmacol Res. 2019 Dec;150:104511.

PMID: 31678210

1

Targeting Glucose Transport and the NAD Pathway in Tumor Cells With STF-31: A Re-Evaluation

Dominik Kraus, Jan Reckenbeil, Nadine Veit, Stefan Kuerpig, Michael Meisenheimer, Imke Beier, Helmut Stark, Jochen Winter, Rainer Probstmeier

Cell Oncol (Dordr). 2018 Oct;41(5):485-494.

PMID: 29949049

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode